Cargando…
Inhibition of LncRNAH19 has the effect of anti‐tumour and enhancing sensitivity to Gefitinib and Chemotherapy in Non‐small‐cell lung cancer in vivo
Lung cancer is one of the most common malignant diseases, which ranked first in both men and women malignancies worldwide. The survival rate of non‐small‐cell lung cancer (NSCLC) has been limited with distant metastasis and shortage of effective chemotherapeutics in recent years. Thus, novel therape...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214165/ https://www.ncbi.nlm.nih.gov/pubmed/32281297 http://dx.doi.org/10.1111/jcmm.15245 |